Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
Significant advances have been made in femoropopliteal stent design and clinical outcomes during the past decade. Initial randomized studies demonstrated superiority of nitinol self-expanding stents to balloon angioplasty for treatment of moderate-length superficial femoral artery stenoses. During longer-term follow-up, first generation nitinol stents were hampered by high rates of stent fracture. A number of newer nitinol stent designs have been developed with improved conformability, greater radial strength and lower rates of long-term stent fracture. These newer stent designs have demonstrated superior primary patency and decreased restenosis for the treatment of moderate-length femoropopliteal lesions relative to historical benchmarks. Recent advances in drug-eluting nitinol stents have also offered treatment options for challenging lesion subsets including very long femoropopliteal lesions and for the treatment of in-stent restenosis. This article reviews recent advances and upcoming research in nitinol self-expanding stent technology for the treatment of superficial femoral and popliteal artery stenosis.
Division of Cardiology, University of Colorado School of Medicine, 1055 Clermont Street, Denver, CO, USA.
Arash
A
Aghel
Ehrin J
EJ
Armstrong
D000497:Alloys; D001157:Arterial Occlusive Diseases / Q000601:surgery*; D004867:Equipment Design; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D011150:Popliteal Artery / Q000601:surgery*; D011474:Prosthesis Design; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D016896:Treatment Outcome
D000497:Alloys; C013616:nitinol
claudication; nitinol stents; peripheral artery disease; popliteal artery; randomized trials; restenosis; stent; superficial femoral artery